New study reveals CKD affects nearly 800 million adults worldwide
The number of adults living with chronic kidney disease (CKD) has more than doubled since 1990, reaching nearly 800 million…
Using estimated risks and preferences to justify intensive BP control in CKD patients
An analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) indicates that nearly all adults with chronic kidney…
Faster acute kidney injury test in development
RMIT University and Australian diagnostic company Nexsen Limited have teamed up to develop point-of-care blood tests designed to…
Genetic risk scores fail to predict survival after diagnosis
New research across seven global biobanks shows that the DNA driving disease onset does not determine survival; instead,…
Cardiovascular and renal outcomes of dual combination therapies with glucagon-like peptide-1 receptor agonists and sodium-glucose transport protein 2 inhibitors: a systematic review and meta-analysis | Cardiovascular Diabetology
Study selection process A total of 3161 studies were retrieved from MEDLINE and EMBASE, with an additional one…
Adding aspirin raises cardiovascular events in high-risk CCS patients on anticoagulants
Adding aspirin increased the risk of cardiovascular events, death and major bleeding in high-risk patients with chronic coronary…
Constipation drug found to slow renal function decline in CKD patients
Chronic kidney disease (CKD) is a major health issue worldwide. Many patients end up requiring regular dialysis to…
Glycosylation emerges as a key player in kidney disease progression
Kidney diseases affect nearly 700 million people worldwide and are a growing cause of mortality and health care…
New blood markers predict kidney disease and mortality in diabetes
Kidney complications in diabetes often progress silently, putting patients at risk of life-threatening outcomes long before any symptoms…